###begin article-title 0
Regulation of Type IV Collagen alpha Chains of Glomerular Epithelial Cells in Diabetic Conditions
###end article-title 0
###begin p 1
###xml 914 915 894 895 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sup>
An early feature of diabetic nephropathy is the alteration of the glomerular basement membrane (GBM), which may result in microalbuminuria, subsequent macroproteinuria, and eventual chronic renal failure. Although type IV collagen is the main component of thickened GBM in diabetic nephropathy, cellular metabolism of each alpha chains of type IV collagen has not been well studied. To investigate the regulation of alpha(IV) chains in diabetic conditions, we examined whether glucose and advanced glycosylation endproduct (AGE) regulate the metabolism of each alpha(IV) chains in the diabetic tissue and glomerular epithelial cells (GEpC). Glomerular collagen alpha3(IV) and alpha5(IV) chains protein were higher and more intense in immunofluorescence staining according to diabetic durations compared to controls. In vitro, mainly high glucose and partly AGE usually increased total collagen protein of GEpC by [3H]-proline incorporation assay and each alpha(IV) chain proteins including alpha1(IV), alpha3(IV), and alpha5(IV) in time-dependent and subchain-specific manners. However, the changes of each alpha(IV) chains mRNA expression was not well correlated to the those of each chain proteins. The present findings suggest that the metabolism of individual alpha(IV) chains of GBM is differentially regulated in diabetic conditions and those changes might be induced not only by transcriptional level but also by post-translational modifications.
###end p 1
###begin title 2
INTRODUCTION
###end title 2
###begin p 3
###xml 191 192 191 192 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B1">1</xref>
###xml 289 290 289 290 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B2">2</xref>
###xml 292 293 292 293 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B3">3</xref>
###xml 492 493 489 490 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B2">2</xref>
###xml 495 496 492 493 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B4">4</xref>
###xml 498 499 495 496 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B5">5</xref>
Diabetic nephropathy and vascular changes remain major complications of diabetes, accounting for up to 40% of cases with end-stage renal disease and 75% of cases with cardiovascular disease (1). Many studies suggest a key role for hyperglycemia in the pathogenesis of these complications (2, 3). Indeed, elevated glucose is known to activate a variety of cells to stimulate extracellular matrix (ECM) synthesis including collagen mediated by stimulating transforming growth factor (TGF)-beta(2, 4, 5).
###end p 3
###begin p 4
###xml 294 295 294 295 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B6">6</xref>
###xml 470 471 470 471 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B1">1</xref>
###xml 472 473 472 473 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B3">3</xref>
Pathologic changes in the glomerular ECM lead to abnormal protein excretion as well as to impairment of glomerular filtration in diabetic nephropathy. Alterations in the diabetic glomerular basement membrane (GBM) include increase in its thickness and decrease in the density of anionic sites (6). The former corresponds to increase in GBM content of collagen forming mesh-like barrier structure which regulates the size-selective aspects of glomerular permselectivity (1-3).
###end p 4
###begin p 5
###xml 128 129 128 129 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B7">7</xref>
###xml 130 131 130 131 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B9">9</xref>
###xml 233 239 233 239 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">COL4A1</italic>
###xml 241 247 241 247 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">COL4A2</italic>
###xml 249 255 249 255 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">COL4A3</italic>
###xml 257 263 257 263 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">COL4A4</italic>
###xml 265 271 265 271 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">COL4A5</italic>
###xml 277 283 277 283 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">COL4A6</italic>
###xml 359 360 351 352 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B9">9</xref>
###xml 361 363 353 355 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B11">11</xref>
###xml 569 570 545 546 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B9">9</xref>
###xml 571 573 547 549 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B13">13</xref>
###xml 848 850 824 826 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B10">10</xref>
###xml 852 854 828 830 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B11">11</xref>
GBM are assembled through an interweaving of type IV collagen (collagen IV) with laminins, nidogen, and sulfated proteoglycans (7-9). Collagen IV belongs to a family of collagenous proteins that has at least 25 distinct members. The COL4A1, COL4A2, COL4A3, COL4A4, COL4A5, and COL4A6 genes encode the six chains of collagen IV, alpha1(IV) through alpha6(IV) (9-11). Type IV collagen chains have a highly regulated distribution in the glomerulus; alpha1 and alpha2 chains are localized to the mesangium, whereas alpha3 through alpha6 chains are found mainly in the GBM (9-13). Type IV collagen of GBM is produced by and attached to podocytes, therefore, type IV collagen of GBM is closely related to podocytes. Dysregulation of GBM collagen chains produces proteinuria and hematuria as seen in Alport's syndrome and Goodpasture syndrome clinically (10, 11). However, the dysregulation of cellular metabolism of individual chains of type IV collagen in podocytes (glomerular epithelial cells; GEpC) has not been well studied in diabetic nephropathy. Our aim in this study was to investigate the regulation of alpha chains of type IV collagen of podocytes that is responsible for the synthesis of GBM in diabetic condition.
###end p 5
###begin title 6
MATERIALS AND METHODS
###end title 6
###begin title 7
Diabetic animals
###end title 7
###begin p 8
###xml 237 256 <span type="species:ncbi:10116">Sprague-Dawley rats</span>
###xml 262 266 <span type="species:ncbi:10116">rats</span>
###xml 371 375 <span type="species:ncbi:10116">rats</span>
Diabetes was induced by a single intravenous injection of streptozotocin (STZ; Sigma Chemical Co., St. Louis, MO, U.S.A.) at 45 mg/kg body weight, freshly dissolved in 0.1 M sterile sodium citrate, pH 4.5, in 6-week-old (180-220 g) male Sprague-Dawley rats. The rats were considered diabetic if blood glucose levels were above 200 mg/dL at 48 hr after STZ injection. The rats remained hyperglycemic throughout experiment were sacrificed at 48 hr, 4 weeks and 10 weeks after the induction of diabetes. The right kidney was removed, weighed, cut into portions, and sectioned at 5 microm for the assessment of immunofluorescence (IF).
###end p 8
###begin title 9
Cell culture
###end title 9
###begin p 10
###xml 102 104 102 104 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B14">14</xref>
###xml 282 284 282 284 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B15">15</xref>
###xml 334 336 334 336 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B15">15</xref>
###xml 0 3 <span type="species:ncbi:10116">Rat</span>
###xml 31 34 <span type="species:ncbi:10116">rat</span>
Rat GEpCs, cloned from primary rat glomerular cultures, were characterized and provided by Kreisberg (14). They were characterized by sensitivity to puromycin aminonucleoside, positive staining for Heymann antigen (gp330) and podocalyxin, whereas negative staining for factor VIII (15). GEpCs were maintained as previously described (15). Experiments were performed with cells between passages 15 and 18.
###end p 10
###begin title 11
Preparation of culture additives
###end title 11
###begin p 12
###xml 445 447 445 447 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B15">15</xref>
###xml 1069 1071 1061 1063 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B15">15</xref>
###xml 117 120 <span type="species:ncbi:10116">Rat</span>
###xml 570 576 <span type="species:ncbi:9913">bovine</span>
###xml 751 757 <span type="species:ncbi:9913">bovine</span>
Cells were serum-deprived to reduce background for 24 hr before each experiment, then exposed to glucose and/or AGE. Rat GEpCs were incubated in culture media containing either 5 mM glucose with 66 unit/mL insulin or 30 mM glucose (high glucose, HG) without insulin in order to mimic the metabolic environment of type I diabetes mellitus. Advanced glycosylation endproducts (AGE) was produced by the technique previously described by Ha et al. (15). To imitate the long-term diabetic condition, AGE was added (5 microg/mL) and controls were established using unmodified bovine serum albumin (BSA) (5 microg/mL). To exclude the effect of additionally produced glycated proteins in culture conditions, no longer than 48 hr of incubation was used. Fetal bovine serum (FBS) was reduced to 0.5% on the last media change to reduce background before protein and RNA extraction. For identification purposes, coating with AGE or BSA was denoted as 'A' or 'B', and addition of glucose at 5 or 30 mM by '5' or '30', respectively. Their meaning of each condition described before (15).
###end p 12
###begin title 13
###xml 1 2 1 2 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sup>
[3H]-proline incorporation
###end title 13
###begin p 14
###xml 60 61 60 61 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sup>
###xml 102 103 102 103 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sup>
Collagen synthesis was assessed by measurement of cellular [3H]-proline uptake. For all experiments, [3H]-proline (PerkinElmer, Boston, MA, U.S.A.) was added to each well at a final concentration of 1 microCi/mL for the last 24 hr in triplicate. After incubation, the media was removed and the cells were washed with ice-cold 10% trichloroacetic acid (TCA) for 30 min at 4℃. After two rinses with cold 10% TCA, the acid-precipitable material was solubilized overnight in 1N NaOH at 37℃ and neutralized with 1N HCl per well. Total protein was determined from an aliquot of each well by Bradford assay (Sigma Chemical Co., St. Louis, MO, U.S.A.). Incorporated radioactivity (dpm) from the resultant supernatant was measured in a liquid scintillation counter and was expressed as percent of control.
###end p 14
###begin title 15
Cellular protein extraction
###end title 15
###begin p 16
###xml 57 60 <span type="species:ncbi:10116">rat</span>
For measuring collagen, cell extracts were prepared from rat GEpCs grown for each duration period under different conditions as described before. At the end of incubation, the confluently grown cell layers were washed twice with phosphate-buffered saline and subsequently extracted in 4 M guanidinium-HCl, 2% CHAPS, and protease inhibitors containing 100 mM 6-aminohexanoic acid, 10 mM benzamidine HCl, and 1 mM phenylmethylsulfonyl fluoride (PMSF) at 4℃ overnight and stored at -20℃ till further analysis. Protein concentrations were determined with a Bio-Rad kit (Bio-Rad Laboratories, Hercules, CA, U.S.A.).
###end p 16
###begin title 17
Western blotting of collagen alpha chains
###end title 17
###begin p 18
###xml 244 248 <span type="species:ncbi:9925">goat</span>
###xml 254 257 <span type="species:ncbi:10116">rat</span>
###xml 375 386 <span type="species:ncbi:3704">horseradish</span>
Thirty microg of boiled extracts was applied on 10% SDS-PAGE gels and transferred to polyvinylidene fluoride membranes (Bio-Rad Laboratories). Then, the membranes were air-dried and blocked in 3% fat-free milk before incubation with monoclonal goat anti-rat collagen alpha1, alpha3, and alpha5 chains (Santa Cruz Biotechnology, Santa Cruz, CA, U.S.A.). After incubation with horseradish peroxidase-conjugated secondary antibodies, bands were detected by using the ECL chemiluminescence system (Amersham Biotech Ltd., Bucks, U.K.). Each band density was measured using densitometry program (Lab-Works 4.0, UVP Inc., Upland, CA, U.S.A.) and controlled by beta-actin amounts.
###end p 18
###begin title 19
RT-PCR analysis of collagen alpha chains
###end title 19
###begin p 20
###xml 72 74 72 74 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B15">15</xref>
###xml 38 41 <span type="species:ncbi:10116">rat</span>
Total RNA was extracted from cultured rat GEpC as previously described (15). After estimating its concentration by UV spectrophotometry, 5 microg of total RNA was used for first-strand cDNA synthesis. Aliquots of the cDNA were amplified using primers for collagen alpha1(IV): sense 5'-TCGGCTATTCCTTCGTGATG-3'and anti-sense 5'-TCTCGCTTCTCTCTATGGTG-3'; alpha3(IV): sense 5'-ATCCTGGTCTTCCTGGACCT-3'and anti-sense 5'-CCATCTCACCAGGACAACCT-3'; collagen alpha5(IV): sense 5'-ATGCTGACTAGCAACCATGA-3'and anti-sense 5'-GCCAGATCACATCTAAATGA-3'. The expression of GAPDH as RNA control was analyzed employing the following primers: sense 5'-CTCTACCCACGGCAAGTTCAA-3'and anti-sense 5'-GGATGACCTTGCCCACAGC-3'. PCR products were visualized on 2% agarose gels, and band density was measured using densitometry program as Western blotting.
###end p 20
###begin title 21
Statistics
###end title 21
###begin p 22
###xml 177 178 175 176 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
The data (cpm per mg cell protein) in each condition of incubation from at least three experiments were expressed as mean+/-SD if not remarked and compared by Student's t test; P<0.05 was considered to be statistically significant.
###end p 22
###begin title 23
RESULTS
###end title 23
###begin title 24
Increased intensity of alpha(IV) chains in diabetic glomeruli
###end title 24
###begin p 25
###xml 151 158 143 150 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F1">Fig. 1A</xref>
###xml 682 689 658 665 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F1">Fig. 1B</xref>
###xml 136 139 <span type="species:ncbi:10116">rat</span>
###xml 350 353 <span type="species:ncbi:10116">rat</span>
Double-staining of alpha5(IV) with P-cadherin and alpha3(IV) showed colocalization in podocyte foot processes around capillary loops in rat glomeruli (Fig. 1A). The observed tissues were obtained at 48 hr, 4 weeks and 10 weeks after the induction of diabetes, of them, urinary albumin excretion increased significantly only in the prolonged diabetic rat (24.5 mg/day at 10 weeks vs. less than 4 mg/day at 48 hr and 4 weeks). IF microscopy of kidney stained with anti-alpha3(IV) and alpha5(IV) antibodies showed that the increased and more intense stainings of glomerular capillary alpha3(IV) and alpha5(IV) chains were observed according to diabetic durations compared to controls (Fig. 1B). There were no glomerular stainings in primary antibodies-negative controls (figures not shown). We also found that there were glomerular hypertrophy and sclerosis in the advanced diabetic kidneys.
###end p 25
###begin title 26
###xml 24 25 24 25 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sup>
High glucose increases [3H]-proline incorporation
###end title 26
###begin p 27
###xml 211 212 211 212 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sup>
###xml 252 258 252 258 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F2">Fig. 2</xref>
###xml 289 290 289 290 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sup>
Compared to incubation of GEpC with 5 mM glucose (B5), 30 mM glucose without insulin (B30), AGE with 5 mM glucose (A5), and AGE with 30 mM glucose (A30) for 48 hr resulted in 55.5%, 20.6, and 50.3% increase in [3H]-proline incorporation, respectively (Fig. 2). Therefore, the increase in [3H]-proline incorporation meaning collagen synthesis might be induced mainly by high glucose.
###end p 27
###begin title 28
High glucose increases alpha chains of type IV collagen by western analysis
###end title 28
###begin p 29
###xml 295 305 275 285 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F3">Fig. 3A, B</xref>
The protein amounts of novel glomerular collagen alpha chains proteins, alpha3(IV) and alpha5(IV) chains, were compared with that of condition B5 at 2, 8, 24, and 48 hr incubation time. Both alpha3(IV) and alpha5(IV) chains, were not changed initially, then, increased at 48 hr by high glucose (Fig. 3A, B). AGE did not showed any additive effect on the novel alpha chains proteins, although alpha5(IV) chain protein increased somewhat since 24 hr incubation. Then, we observed the changes of alpha1(IV) and alpha5(IV) chains proteins at 48 hr incubation.
###end p 29
###begin p 30
###xml 217 218 213 214 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 231 238 227 234 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F3">Fig. 3C</xref>
###xml 478 479 470 471 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 492 499 484 491 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F3">Fig. 3D</xref>
Densitometric analysis of alpha1(IV) chain by Western blotting revealed a 46% increase in high glucose condition (B30) and 50% increase in high glucose and AGE condition (A30) at 48 hr incubation compared to B5 (n=3, P<0.05, both, Fig. 3C). However, these changes were not found in the A5 and osmotic control (Aosm). alpha5(IV) chain also revealed a 66% increase in high glucose condition (B30) and 2.2 fold increase in high glucose and AGE condition (A30) compared to B5 (n=3, P<0.05, both, Fig. 3D). However, these changes were not found in the A5 and osmotic control (Aosm) as the results of alpha1(IV) chain. The increased amount of alpha1 and alpha5 chains protein in high glucose-added conditions (B30 and A30) was much more than that of A5 and Aosm, implying that high glucose might have more influence on the amount of alpha1 and alpha5 chains protein of GEpC than AGE and osmolality.
###end p 30
###begin title 31
Gene expression of alpha chains of type IV collagen by high glucose and AGE
###end title 31
###begin p 32
###xml 409 418 393 402 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F4">Fig. 4A-C</xref>
The expression levels of mRNA for alpha1(IV), alpha3(IV), and alpha5(IV) in each condition were compared with that of condition B5 at 2, 8, 24, and 48 hr incubation time. GAPDH mRNA was not significantly different in all PCR products. According to incubation time, mRNA expression of each alpha chain showed the slightly increasing tendency in chain-different manners, however, their significances were rare (Fig. 4A-C). Then, we observed the changes of each chains expression at 48 hr incubation.
###end p 32
###begin p 33
###xml 103 104 99 100 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 169 176 165 172 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F4">Fig. 4D</xref>
###xml 277 287 265 275 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F4">Fig. 4E, F</xref>
###xml 290 297 278 285 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F4">Fig. 4C</xref>
###xml 491 498 475 482 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F4">Fig. 4F</xref>
There were significantly increased alpha1(IV) chain mRNA only in A30 condition (25%, compared with B5 (P<0.05), however, no significant changes in the other conditions (Fig. 4D). And, there are no significant changes of alpha3(IV) and alpha5(IV) chains mRNA in any conditions (Fig. 4E, F). Fig. 4C showed that the expression levels of mRNA for alpha5(IV) in each condition increased compared with those of condition B5 at early stages, 2, 8, and 24, however, not at 48 hr incubation time in Fig. 4F.
###end p 33
###begin title 34
DISCUSSION
###end title 34
###begin p 35
###xml 105 106 105 106 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B6">6</xref>
###xml 108 110 108 110 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B16">16</xref>
###xml 311 312 311 312 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B1">1</xref>
###xml 314 315 314 315 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B3">3</xref>
###xml 470 471 470 471 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B6">6</xref>
###xml 473 475 473 475 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B16">16</xref>
###xml 477 479 477 479 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B17">17</xref>
###xml 602 604 602 604 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B18">18</xref>
###xml 996 998 993 995 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B18">18</xref>
###xml 999 1001 996 998 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B20">20</xref>
###xml 1144 1146 1141 1143 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B21">21</xref>
###xml 1084 1092 <span type="species:ncbi:9606">patients</span>
Diabetic glomerulopathy is characterized by thickening of the GBM and expansion of the mesangial matrix (6, 16). An early feature of diabetic nephropathy is the alteration of the glomerular basement membrane (GBM), which may result in microalbuminuria, subsequent overt proteinuria, and eventual renal failure (1, 3). As for the GBM, its conspicuous thickening in diabetes, perhaps due to accumulation of collagen IV and alterations in its architecture and composition (6, 16, 17), would seem to constitute a more effective barrier to the filtration of proteins but is in fact more porous to proteins (18). The glomerular visceral epithelial cell, called podocyte is also affected by the early pathologic changes in diabetic glomerulopathy, including overproduction of cytokines such as VEGF and TGFbeta, widened foot processes width (hypertrophy), podocytopenia, and the dysregulation of GBM components, all of which contribute to the initiation of proteinuria and progression of renal disease (18-20). Because the onset and progression of diabetic glomerulosclerosis are delayed in patients who achieve an adequate level of glycemic control (21), hyperglycemia is thought to be an important regulator of glomerular lesion development.
###end p 35
###begin p 36
###xml 108 109 108 109 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B7">7</xref>
###xml 110 111 110 111 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B9">9</xref>
###xml 218 219 210 211 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B9">9</xref>
###xml 220 222 212 214 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B11">11</xref>
###xml 270 271 262 263 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B7">7</xref>
###xml 272 273 264 265 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B9">9</xref>
###xml 275 277 267 269 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B12">12</xref>
###xml 404 405 396 397 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B7">7</xref>
###xml 407 409 399 401 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B12">12</xref>
###xml 682 683 654 655 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B9">9</xref>
###xml 684 686 656 658 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B13">13</xref>
###xml 688 690 660 662 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B16">16</xref>
GBM is composed of several macromolecules, including type IV collagen, laminin, proteoglycan, and entactin (7-9). Type IV collagen, which includes six genetically distinct isoforms named alpha1(IV) through alpha6(IV) (9-11), is the most abundant constituent of the GBM (7-9, 12). These isoforms organize themselves into a unique network, which provides GBM structural stability and unique functionality (7, 12). Different isoforms of type IV collagen are specific for each glomerular compartment. The novel alpha3(IV), alpha4(IV), and alpha5(IV) chains are predominantly associated with the GBM, while classical alpha1(IV) and alpha2(IV) chains are present in the mesangial matrix (9-13, 16).
###end p 36
###begin p 37
###xml 525 527 501 503 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B22">22</xref>
###xml 814 816 782 784 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B22">22</xref>
###xml 818 820 786 788 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B23">23</xref>
###xml 353 356 <span type="species:ncbi:10116">rat</span>
###xml 388 391 <span type="species:ncbi:10116">rat</span>
###xml 537 542 <span type="species:ncbi:9606">human</span>
###xml 695 700 <span type="species:ncbi:9606">Human</span>
###xml 802 805 <span type="species:ncbi:10116">rat</span>
At all developmental stages of kidney morphogenesis, alpha1 and alpha2(IV) chains were seen in basement membranes. Collagen alpha3-5(IV) chains, on the other hand, were not found in fetal nephron at the primary vesicle, S-shaped body and capillary loop stages but emerged during later development of the nephron. This is in line with earlier studies on rat tissues suggesting that in the rat, alpha3-5(IV) chains are first expressed and start replacing alpha1 and alpha2(IV) chains in glomerulus at the capillary loop stage (22). In the human kidney, however, this switch seems to appear at a distinctly later stage of development, reflecting species-specific differences in kidney development. Human kidney also shows expression of alpha1 and alpha2(IV) chains in GBM, which is not seen in developing rat kidney (22, 23)
###end p 37
###begin p 38
###xml 165 167 165 167 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B10">10</xref>
###xml 169 171 169 171 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B11">11</xref>
Dysregulation of GBM collagen chains produces proteinuria and hematuria genetically or acquired as seen in Alport's syndrome and Goodpasture syndrome, respectively (10, 11). However, the dysregulation of cellular metabolism of individual chains of type IV collagen has not been well studied in diabetic nephropathy.
###end p 38
###begin p 39
###xml 181 183 177 179 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B24">24</xref>
###xml 313 315 309 311 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B24">24</xref>
###xml 627 629 615 617 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B25">25</xref>
###xml 784 790 764 770 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F1">Fig. 1</xref>
###xml 799 804 779 784 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">db/db</italic>
###xml 953 957 925 929 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">db/m</italic>
###xml 968 970 940 942 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B26">26</xref>
###xml 1198 1200 1162 1164 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B27">27</xref>
###xml 1202 1204 1166 1168 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B28">28</xref>
###xml 1416 1418 1372 1374 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B27">27</xref>
###xml 1420 1422 1376 1378 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B28">28</xref>
###xml 24 28 <span type="species:ncbi:10116">rats</span>
###xml 208 212 <span type="species:ncbi:10116">rats</span>
###xml 520 524 <span type="species:ncbi:10116">rats</span>
###xml 805 809 <span type="species:ncbi:10090">mice</span>
###xml 976 981 <span type="species:ncbi:9606">human</span>
###xml 1150 1157 <span type="species:ncbi:9606">patient</span>
###xml 1374 1382 <span type="species:ncbi:9606">patients</span>
In STZ-induced diabetic rats, the mRNA levels for the alpha1(IV) collagen chain increased significantly with age even before morphological thickening of basement membrane occurred (24). Treating the diabetic rats with insulin for 4 weeks ameliorated the abnormally regulated ECM gene expression in the glomeruli (24). These data suggest that hyperglycemia may play a role in the abnormal ECM gene expression in vivo. The mRNA levels for the alpha5(IV) collagen chain also increased significantly in STZ-induced diabetic rats at month 1 but not at month 4, whereas collagen alpha5(IV) protein was higher at both 1 and 4 months (25). We also found that both novel collagen chains, alpha3(IV) and alpha5(IV) chains, increased in the GBM of experimental overt diabetic tissues as seen in Fig. 1. In the db/db mice, there was a significant reduction of alpha3(IV) collagen protein in renal cortex but not of alpha5(IV) collagen subchain in compared with the db/m controls (26). In human diabetic kidney tissue, there was intense staining for alpha3(IV) NC and alpha4(IV) NC domain in the GBM but not in the mesangial matrix of type I and type II diabetic patient tissue with overt diabetic nephropathy (27, 28). In contrast, staining with antibodies to alpha1(IV) NC and alpha2(IV) NC domain reacted with mesangial matrix but appeared to diminish significantly in the GBM in the patients with overt diabetic nephropathy (27, 28).
###end p 39
###begin p 40
###xml 29 31 29 31 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B25">25</xref>
###xml 409 411 401 403 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B29">29</xref>
###xml 108 113 <span type="species:ncbi:10090">mouse</span>
###xml 441 446 <span type="species:ncbi:10090">mouse</span>
In vitro study, Kang et al. (25) reported that collagen alpha5(IV)/GAPDH mRNA ratio and protein of cultured mouse podocytes were higher in high glucose for 10 days incubation than in low (normal) glucose. These results are similar to our results on the change of alpha5 chain mRNA levels at early stages although not significant later, as cultured cells might not be identical. On the other hand, Bai et al. (29) demonstrated using cultured mouse podocytes that high glucose decreased the protein levels of alpha5(IV) chain significantly during 3-4 days incubation, whereas, increased MMP-9 activity and mRNA levels, suggesting that the change of GBM collagen would be caused by an imbalance in ECM synthesis and degradation. We also found that high glucose induced the increased amount of alpha1(IV), alpha3(IV), and alpha5(IV) chains protein at late stage. On the other hand, high glucose induced the mRNA expression of alpha5(IV) and partly alpha1(IV) at early stage but not at late stage. The incoordination between alpha(IV) chains protein and their mRNA expression at each stage suggest that the increased amount of alpha5(IV) chains protein in high glucoseadded conditions may be induced by transcriptional metabolic imbalance at early stage but much more by post-translational modification including structural changes by glycosylation mostly at late stage. On the other hand, the other alpha(IV) chains might be regulated much more by post-translational modification including structural changes by glycosylation and/or metabolic imbalance in time-dependent and isoform-specific manners. Similarly, AGE also induced the increased amount of alpha1(IV), alpha3(IV), and alpha5(IV) chains protein at late stage and the mRNA expression of alpha5(IV) at early stage and alpha1(IV) at late stage. These changes induced by AGE also suggest that alpha(IV) chains might be regulated not only by transcriptional level but also by post-translational modification including structural changes by glycosylation and/or metabolic imbalance in time-dependent and subchain-specific manners. Additive effects by AGE were not evident.
###end p 40
###begin p 41
###xml 203 205 199 201 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B30">30</xref>
###xml 242 244 235 237 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B25">25</xref>
###xml 256 258 249 251 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B24">24</xref>
###xml 291 293 284 286 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B28">28</xref>
Although the mechanisms of increased each alpha chains of type IV collagen would not be clearly elucidated because of their different expressions, many researchers suggested the roles of angiotensin II (30), TGF-beta, PKC-p38 MAPK signaling (25), insulin (24), decreased matrix degradation (28), etc. as the initiator and modulator of type IV collagen dysregulation in diabetic environments. According to the our present and previous studies, diabetic conditions induced the dysregulation of glomerular alpha(IV) chains by transcriptional and post-translational modification with a discrepancy in the species-, strains-, time-, cell-, and/or subchain-dependent manners. The mechanisms of the changes of type IV collagen alpha chains would be further elucidated for the regulation of type IV collagen biosynthesis.
###end p 41
###begin p 42
In conclusion, we suggest that the metabolism of individual alpha(IV) chains of GBM is differentially regulated in diabetic conditions and the change of each alpha chains would be induced by transcriptional level and post-translational modification including structural changes by glycosylation and/or metabolic imbalance in time-dependent and isoform-specific manners.
###end p 42
###begin title 43
ACKNOWLEDGMENTS
###end title 43
###begin p 44
The authors thank Dr. K-D Han for his preparation for STZ-induced diabetic nephropathy and BS Kasinath for study idea.
###end p 44
###begin p 45
###xml 44 91 44 91 <funding-source xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Korea Science and Engineering Foundation (KOSEF</funding-source>
###xml 93 113 93 113 <award-id xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">R01-2007-000-20856-0</award-id>
###xml 119 144 119 144 <funding-source xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Korea Research Foundation</funding-source>
###xml 195 201 195 201 <funding-source xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MOEHRD</funding-source>
###xml 235 250 235 250 <award-id xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">KRF-2007-E00269</award-id>
This work was supported by grants from from Korea Science and Engineering Foundation (KOSEF, R01-2007-000-20856-0) and Korea Research Foundation Grant funded by the Republic of Korea Government (MOEHRD, Basic Research Promotion Fund) (KRF-2007-E00269).
###end p 45
###begin article-title 46
Diabetes, hypertension, and cardiovascular disease: an update
###end article-title 46
###begin article-title 47
Hyperglycemia and diabetic kidney disease. The case for transforming growth factor-beta as a key mediator
###end article-title 47
###begin article-title 48
Pathogenesis, prevention, and treatment of diabetic nephropathy
###end article-title 48
###begin article-title 49
###xml 65 71 <span type="species:ncbi:10090">murine</span>
Stimulation of collagen gene expression and protein synthesis in murine mesangial cells by high glucose is mediated by autocrine activation of transforming growth factor-beta
###end article-title 49
###begin article-title 50
Transcriptional activation of transforming growth factor-beta1 in mesangial cell culture by high glucose concentration
###end article-title 50
###begin article-title 51
The extracellular matrix in diabetic nephropathy
###end article-title 51
###begin article-title 52
Analysis of basement membrane self-assembly and cellular interactions with native and recombinant glycoproteins
###end article-title 52
###begin article-title 53
Structure and biological activity of the extracellular matrix
###end article-title 53
###begin article-title 54
Renal basement membrane components
###end article-title 54
###begin article-title 55
Identification of a distinct type IV collagen alpha chain with restricted kidney distribution and assignment of its gene to the locus of X chromosome-linked Alport syndrome
###end article-title 55
###begin article-title 56
Alport's syndrome, Goodpasture's syndrome, and type IV collagen
###end article-title 56
###begin article-title 57
A network model for the organization of type IV collagen molecules in basement membranes
###end article-title 57
###begin article-title 58
Type IV collagen of the glomerular basement membrane: evidence that the chain specificity of network assembly is encoded by the noncollagenous NC1 domains
###end article-title 58
###begin article-title 59
###xml 34 37 <span type="species:ncbi:10116">rat</span>
Isolation and characterization of rat glomerular epithelial cells in vitro
###end article-title 59
###begin article-title 60
Effects of advanced glycosylation endproducts on perlecan core protein of glomerular epithelium
###end article-title 60
###begin article-title 61
Glomerular distribution of type IV collagen in diabetes by high resolution quantitative immunochemistry
###end article-title 61
###begin article-title 62
From the periphery of the glomerular capillary wall toward the center of disease: podocyte injury comes of age in diabetic nephropathy
###end article-title 62
###begin article-title 63
###xml 134 138 <span type="species:ncbi:10116">rats</span>
Initial ultrastructural changes in pore size and anionic sites of the glomerular basement membrane in streptozotocin-induced diabetic rats and their prevention by insulin treatment
###end article-title 63
###begin article-title 64
Biochemical events and cytokine interactions linking glucose metabolism to the development of diabetic nephropathy
###end article-title 64
###begin article-title 65
###xml 85 93 <span type="species:ncbi:9606">patients</span>
Structural alterations to the podocyte are related to proteinuria in type 2 diabetic patients
###end article-title 65
###begin article-title 66
###xml 129 137 <span type="species:ncbi:9606">patients</span>
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33)
###end article-title 66
###begin article-title 67
Collagen IV alpha 3, alpha 4, and alpha 5 chains in rodent basal laminae: sequence, distribution, association with laminins, and developmental switches
###end article-title 67
###begin article-title 68
Developmental biology of glomerular basement membrane components
###end article-title 68
###begin article-title 69
###xml 62 66 <span type="species:ncbi:10116">rats</span>
ECM gene expression and its modulation by insulin in diabetic rats
###end article-title 69
###begin article-title 70
Role of 12-lipoxygenase in the stimulation of p38 mitogen-activated protein kinase and collagen alpha5(IV) in experimental diabetic nephropathy and in glucose-stimulated podocytes
###end article-title 70
###begin article-title 71
Inhibiting albumin glycation attenuates dysregulation of VEGFR-1 and collagen IV subchain production and the development of renal insufficiency
###end article-title 71
###begin article-title 72
Differential expression of basement membrane collagen chains in diabetic nephropathy
###end article-title 72
###begin article-title 73
###xml 56 64 <span type="species:ncbi:9606">patients</span>
Differential distribution of type IV collagen chains in patients with diabetic nephropathy in non-insulin-dependent diabetes mellitus
###end article-title 73
###begin article-title 74
High ambient glucose levels modulates the production of MMP-9 and alpha5(IV) collagen by cultured podocytes
###end article-title 74
###begin article-title 75
###xml 60 65 <span type="species:ncbi:10090">mouse</span>
Angiotensin II stimulates alpha3(IV) collagen production in mouse podocytes via TGF-beta and VEGF signalling: implications for diabetic glomerulopathy
###end article-title 75
###begin p 76
###xml 74 75 66 67 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</bold>
###xml 273 274 257 258 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</bold>
###xml 60 63 <span type="species:ncbi:10116">rat</span>
###xml 213 216 <span type="species:ncbi:10116">rat</span>
###xml 309 312 <span type="species:ncbi:10116">rat</span>
Immunofluorescence staining of alpha3(IV) and alpha5(IV) in rat tissues. (A) Double-staining of alpha5(IV) with P-cadherin and alpha3(IV) showed colocalization in podocyte foot processes around capillary loops in rat glomeruli at 48 hr of diabetes (magnification x1,000). (B) Immunofluorescence microscopy of rat kidney tissue stained with anti-alpha3(IV) and alpha5(IV) antibodies at each experimental time (magnification x400). The further diabetic nephropathy advanced, the more intense stainings of alpha3(IV) and alpha5(IV) chains along the glomerular capillaries were observed compared with those of age-matched controls.
###end p 76
###begin p 77
###xml 1 2 1 2 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sup>
###xml 76 77 76 77 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sup>
###xml 125 126 125 126 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">*</sup>
###xml 126 127 126 127 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
[3H]-Proline incorporation by high glucose and AGE. High glucose increased [3H]-proline incorporation of GEpC significantly (*P<0.05).
###end p 77
###begin p 78
###xml 106 107 102 103 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</bold>
###xml 153 154 145 146 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</bold>
###xml 309 310 289 290 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</bold>
###xml 423 424 399 400 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">D</bold>
###xml 678 679 637 638 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">*</sup>
###xml 679 680 638 639 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
Effects of glucose and AGE on the alpha(IV) chains protein in cultured GEpC assayed by Western blotting. (A) Sequential changes of alpha3(IV) proteins, (B) Sequential changes of alpha5(IV) proteins ; Both alpha3(IV) and alpha5(IV) chains were not changed initially, then, increased at 48 hr by high glucose, (C) High glucose (B30 and A30) increased the amounts of alpha1(IV) proteins significantly compared with group B5, (D) High glucose (B30 and A30) increased the amounts of alpha5(IV) proteins significantly compared with group B5. Data on the densitometric analysis of alpha1(IV) and alpha5(IV)/beta-actin ratio are expressed as mean+/-SD. Control (100%); the value of B5. *P<0.05 versus control.
###end p 78
###begin p 79
###xml 111 112 103 104 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</bold>
###xml 132 133 120 121 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</bold>
###xml 153 154 137 138 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</bold>
###xml 158 159 142 143 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">D</bold>
###xml 314 315 290 291 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E</bold>
###xml 338 339 310 311 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">F</bold>
###xml 488 489 454 455 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">*</sup>
###xml 489 490 455 456 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
Regulation of alpha(IV) chains mRNA in cultured GEpC assayed by RT-PCR. Sequential changes of alpha1(IV) mRNA (A), alpha3(IV) mRNA (B), alpha5(IV) mRNA (C). (D) High glucose and AGE (A30) increased the amounts of alpha1(IV) mRNA significantly at 48 hr incubation compared with group B5. Change of alpha3(IV) mRNA (E) and alpha5(IV) mRNA (F) at 48 hr incubation. Data on the densitometric analysis of each alpha(IV)/GAPDH ratio are expressed as mean+/-SD. Control (100%); the value of B5. *P<0.05.
###end p 79

